---
title: "Goldman Sachs Remains a Buy on Denali Therapeutics (DNLI)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293392778.md"
description: "Goldman Sachs maintained a Buy rating on Denali Therapeutics (DNLI) with a $41.00 price target, despite shares closing at $22.90. The stock holds a Strong Buy consensus with an average target of $34.82, implying 52% upside. Additionally, Deutsche Bank assigned a Buy rating with a $35.00 target in a July 16 report."
datetime: "2026-07-21T22:40:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293392778.md)
  - [en](https://longbridge.com/en/news/293392778.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293392778.md)
generator: "portal-rs"
---

# Goldman Sachs Remains a Buy on Denali Therapeutics (DNLI)

Goldman Sachs analyst maintained a Buy rating on Denali Therapeutics yesterday and set a price target of $41.00. The company’s shares closed today at $22.90.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Denali Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $34.82, representing a 52.05% upside. In a report released on July 16, Deutsche Bank also assigned a Buy rating to the stock with a $35.00 price target.

### Related Stocks

- [DNLI.US](https://longbridge.com/en/quote/DNLI.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)
- [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md)
- [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md)

## Related News & Research

- [B. Metzler seel. Sohn & Co. AG Buys New Stake in Denali Therapeutics Inc. $DNLI](https://longbridge.com/en/news/296694335.md)
- [The Manufacturers Life Insurance Company Lowers Stock Holdings in Denali Therapeutics Inc. $DNLI](https://longbridge.com/en/news/295319473.md)
- [Alliance Global Partners Reaffirms Their Buy Rating on Pelthos Therapeutics (PTHS)](https://longbridge.com/en/news/296781912.md)
- [Roth MKM Sticks to Its Buy Rating for Coya Therapeutics, Inc. (COYA)](https://longbridge.com/en/news/296711581.md)
- [Piper Sandler Reaffirms Their Buy Rating on Akebia Therapeutics (AKBA)](https://longbridge.com/en/news/296105482.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**